NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
基本信息
- 批准号:9570589
- 负责人:
- 金额:$ 133.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AllelesAnimal ModelAnimalsArchivesAreaBacteriaBreedingCell LineCellsChimera organismClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesCryopreservationDNADisastersDissectionES Cell LineEmbryoEthylnitrosoureaFemaleFertilization in VitroFibroblastsFreezingGene TargetingGene Transfer TechniquesGene-ModifiedGenerationsGenesGenetically Engineered MouseGenotypeGoalsGuide RNAHarvestHybrid CellsHybridsIn VitroInjection of therapeutic agentKnockout MiceLocationMAP Kinase GeneMethodsModelingMusMutant Strains MiceNational Human Genome Research InstituteNatural ImmunityOocytesPathway interactionsProductionProtocols documentationReagentResearchResearch PersonnelRibonucleasesServicesSiteStandardizationSystemTechnologyTeratomaTimeTransfectionTransgenic MiceTransgenic OrganismsWorkdesign and constructionembryo cellembryonic stem cellexperimental studygenome editingimmunocytochemistryinduced pluripotent stem cellinhibitor/antagonistmalemutant mouse modelnucleasepluripotencyprogramssperm celluser-friendlyzygote
项目摘要
The NHGRI Embryonic Stem Cell and Transgenic Mouse Core provides a shared service to NHGRI investigators. The Core specializes in generating genetically engineered mice (GEM) via conventional transgenesis, ES cell targeting, and more recently genome editing using site-specific nucleases (CRISPR/Cas). To do this work, the Core breeds, in-house, 90% of the animals to be used for generating GEM. The Core utilizes several background strains for generating mice and has developed and characterized embryonic stem cells from C57Bl/6J, C57Bl/6N, C57Bl/6 albino, 129S6Sv/Ev, and 129.B6(GFP). We also have a colony of various Cre expressing mice and other transgenics that are used by investigators across many protocols, thereby maximizing the efficiency and reducing mouse numbers by breeding for multiple users. All important mice are cryopreserved and stored in 2 separate locations for disaster purposes. All imported mice are rederived into the Core by in vitro fertilization. We routinely genotype mice and have adapted efficient protocols to minimize mice, reagents and time. The Core supports NHGRI investigators in construct design for gene targeting and transgenesis, and in basic manipulations of mouse husbandry. Other services provided by the Core to help serve NHGRI investigators include ENU injection, teratoma analysis, embryo harvest and dissection, isolation of mouse embryonic fibroblasts and generation of induced pluripotent stem cells. These services allow NHGRI investigators to take full advantage of the mouse as a model organism. Thus, the Core not only generates mice, but we facilitate and enable investigators to perform mouse experiments in areas where they have less expertise.
The NHGRI Transgenic Core is at the forefront of a major increase in transgenic production using CRISPR/Cas gene-editing constructs via injection into oocytes. This technology is replacing the generation of conventional knockout mice using embryonic stem cells and has made the technology more user friendly to a variety of investigators and allows NHGRI to be at the cutting edge of this new and important genomic editing technology in mammalian models. The core generated targeted transgenics using the CRISPR/Cas system for over 100 constructs since January 2014. Additionally, there were over 100 transgenic lines cryopreserved due to the efficiency of CRISPR/Cas to generate multiple alleles.
NHGRI胚胎干细胞和转基因小鼠核心为NHGRI研究人员提供了共享服务。Core专门通过传统的转基因、ES细胞靶向,以及最近使用位点特异性核酸酶(CRISPR/CAS)的基因组编辑来生成基因工程小鼠(GEM)。为了完成这项工作,Core在内部饲养了90%用于制造宝石的动物。Core利用了几种背景菌株来产生小鼠,并开发了C57BL/6J、C57BL/6N、C57BL/6白化、129S6Sv/EV和129.B6(GFP)的胚胎干细胞并进行了鉴定。我们还有一群表达Cre的小鼠和其他转基因动物,研究人员可以跨多种方案使用它们,从而通过为多个用户繁殖来最大化效率并减少小鼠数量。所有重要的小鼠都被冷冻保存,并存放在两个不同的位置,以备灾难之用。所有进口的小鼠都通过体外受精重新获得核心。我们常规地对小鼠进行基因分型,并采用了有效的方案,以最大限度地减少小鼠、试剂和时间。该核心支持NHGRI研究人员进行基因打靶和转基因的构建设计,以及小鼠饲养的基本操作。Core为NHGRI研究人员提供的其他服务包括ENU注射、畸胎瘤分析、胚胎采集和解剖、小鼠胚胎成纤维细胞的分离以及诱导多能干细胞的产生。这些服务使NHGRI的研究人员能够充分利用小鼠作为模式生物的优势。因此,核心不仅产生老鼠,而且我们促进并使研究人员能够在他们专业知识较少的领域进行老鼠实验。
NHGRI转基因核心是通过注射到卵母细胞中使用CRISPR/Cas基因编辑构建物来大幅增加转基因生产的前沿。这项技术正在取代使用胚胎干细胞产生的传统基因敲除小鼠,并使该技术对各种研究人员更加用户友好,并使NHGRI处于这一新的、重要的哺乳动物模型基因组编辑技术的前沿。自2014年1月以来,核心利用CRISPR/CAS系统为100多个结构产生了有针对性的转基因。此外,由于CRISPR/CAs具有产生多个等位基因的效率,目前已有100多个转基因品系超低温保存。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa Garrett其他文献
Lisa Garrett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa Garrett', 18)}}的其他基金
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
- 批准号:
10267134 - 财政年份:
- 资助金额:
$ 133.58万 - 项目类别:
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
- 批准号:
10901696 - 财政年份:
- 资助金额:
$ 133.58万 - 项目类别:
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
- 批准号:
10022469 - 财政年份:
- 资助金额:
$ 133.58万 - 项目类别:
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
- 批准号:
9152767 - 财政年份:
- 资助金额:
$ 133.58万 - 项目类别:
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
- 批准号:
10691160 - 财政年份:
- 资助金额:
$ 133.58万 - 项目类别:
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
- 批准号:
8948412 - 财政年份:
- 资助金额:
$ 133.58万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 133.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists